SLS Europe attends the TBVI Annual Symposium 2025

We are excited to announce our presence at the TBVI symposium 2025 in Les Diablerets, Switzerland, on January 28-29, 2025! Join us at this pivotal event where our Director Clinical Operations, Dr. Sina Brückner, and Project Manager, Dr. Carsten W. Höß, will be presenting our leading TB vaccine candidate, VPM1002.

As we unit with global leaders in the TB field, we are enthusiastic about contributing to the discourse on advancing innovation within the TB vaccine landscape. Beyond presenting VPM1002, we are committed to fostering collaboration in TB research.

The TBVI symposium provides a platform to connect, exchange insights, and collectively push the boundaries of TB vaccine research. We will be sharing our experiences and insights gained during this collaborative gathering. Keep an eye out for updates!